Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, August 15, 2024
[ Thu, Aug 15th 2024
] - WOPRAI
[ Thu, Aug 15th 2024
] - WOPRAI
[ Thu, Aug 15th 2024
] - WOPRAI
[ Thu, Aug 15th 2024
] - WOPRAI
[ Thu, Aug 15th 2024
] - WOPRAI
[ Thu, Aug 15th 2024
] - WOPRAI
[ Thu, Aug 15th 2024
] - WOPRAI
[ Thu, Aug 15th 2024
] - WOPRAI
[ Thu, Aug 15th 2024
] - WOPRAI
[ Thu, Aug 15th 2024
] - WOPRAI
[ Thu, Aug 15th 2024
] - WOPRAI
[ Thu, Aug 15th 2024
] - WOPRAI
[ Thu, Aug 15th 2024
] - WOPRAI
[ Thu, Aug 15th 2024
] - WOPRAI
[ Thu, Aug 15th 2024
] - WOPRAI
[ Thu, Aug 15th 2024
] - WOPRAI
[ Thu, Aug 15th 2024
] - WOPRAI
[ Thu, Aug 15th 2024
] - WOPRAI
[ Thu, Aug 15th 2024
] - WOPRAI
[ Thu, Aug 15th 2024
] - WOPRAI
[ Thu, Aug 15th 2024
] - WOPRAI
[ Thu, Aug 15th 2024
] - WOPRAI
[ Thu, Aug 15th 2024
] - WOPRAI
[ Thu, Aug 15th 2024
] - WOPRAI
[ Thu, Aug 15th 2024
] - WOPRAI
[ Thu, Aug 15th 2024
] - WOPRAI
[ Thu, Aug 15th 2024
] - WOPRAI
[ Thu, Aug 15th 2024
] - WOPRAI
[ Thu, Aug 15th 2024
] - WOPRAI
Gregory Renza Maintained (VIRX) at Buy with Decreased Target to $4 on, Aug 15th, 2024
Gregory Renza of RBC Capital, Maintained "Viracta Therapeutics, Inc." (VIRX) at Buy with Decreased Target from $6 to $4 on, Aug 15th, 2024.
Gregory has made no other calls on VIRX in the last 4 months.
There are 2 other peers that have a rating on VIRX. Out of the 2 peers that are also analyzing VIRX, 0 agree with Gregory's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Gregory
- Hartaj Singh of "Oppenheimer" Maintained at Buy with Decreased Target to $11 on, Thursday, May 23rd, 2024
- Robert Burns of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $4 on, Tuesday, April 16th, 2024
